P. H. Wiernik
- Hematology top 5%
- Acute Myeloid Leukemia Research 3
- Platelet Disorders and Treatments 2
- Biochemistry top 10%
- Blood transfusion and management 3
- Molecular Medicine top 10%
- Clinical Biochemistry top 10%
- Bacterial Identification and Susceptibility Testing 2
-
- Neutropenia and Cancer Infections 5
- Cancer Treatment and Pharmacology 4
-
- Hematological disorders and diagnostics 3
-
- Acute Lymphoblastic Leukemia research 2
- Co-authors
- Joseph AisnerS. C. SchimpffJames H. DuncanStephen C. SchimpffWilliam H. GreeneViola Mae YoungCA SchifferNobuo Oguma
- Partner nations
- United StatesMalaysiaAustralia
In The Last Decade
P. H. Wiernik
19 papers receiving 453 citations
Peers
Comparison fields: 5 of 74
- Hematology 162
- Biochemistry 66
- Molecular Medicine 40
- Clinical Biochemistry 53
- Critical Care and Intensive Care Medicine 37
Countries citing papers authored by P. H. Wiernik
This map shows the geographic impact of P. H. Wiernik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. H. Wiernik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. H. Wiernik more than expected).
Fields of papers citing papers by P. H. Wiernik
This network shows the impact of papers produced by P. H. Wiernik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. H. Wiernik. The network helps show where P. H. Wiernik may publish in the future.
Co-authorship network
The 25 scholars most cited alongside P. H. Wiernik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 25 | |
| 2 | The role of recombinant interleukin-2 in therapy for hematologic malignancies. | 1993 | 6 |
| 3 | Post-remission therapy in adults with acute myelogenous leukemia: the Eastern Cooperative Oncology Group (ECOG) experience. | 1992 | 6 |
| 4 | 1990 | 4 | |
| 5 | 1987 | 41 | |
| 6 | Chromosomal alterations in acute leukemia patients studied with improved culture methods. | 1985 | 75 |
| 7 | 1983 | 27 | |
| 8 | A clinical program of platelet cryopreservation. | 1982 | 19 |
| 9 | High-dose cis-diamminedichloro-platinum therapy in patients with advanced breast cancer: pharmacokinetics, toxicity, and therapeutic efficacy. | 1980 | 42 |
| 10 | Combination chemotherapy of advanced breast cancer with adriamycin and VP 16-213 | 1979 | 2 |
| 11 | 1979 | 9 | |
| 12 | Platelet transfusion therapy for patients with leukemia. | 1978 | 17 |
| 13 | Current status of granulocyte transfusion therapy. | 1977 | 8 |
| 14 | 1975 | 34 | |
| 15 | 1974 | 86 | |
| 16 | 1973 | 3 | |
| 17 | 1972 | 3 | |
| 18 | 1972 | 73 | |
| 19 | 1971 | 46 |
About P. H. Wiernik
P. H. Wiernik is a scholar working on Hematology, Biochemistry and Oncology, having authored 19 papers that have together received 526 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (5 papers), Cancer Treatment and Pharmacology (4 papers), Acute Myeloid Leukemia Research (3 papers), Blood transfusion and management (3 papers), Hematological disorders and diagnostics (3 papers), Platelet Disorders and Treatments (2 papers), Bacterial Identification and Susceptibility Testing (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Hematology (162 citations), Biochemistry (66 citations) and Molecular Medicine (40 citations). P. H. Wiernik has collaborated with scholars based in United States, Malaysia and Australia. Frequent co-authors include Joseph Aisner, S. C. Schimpff, James H. Duncan, Stephen C. Schimpff, William H. Greene, Viola Mae Young, CA Schiffer, Nobuo Oguma, Joseph R. Testa and S Misawa. Their work appears in journals such as The Lancet, Transfusion, Clinical and Experimental Dermatology, The Journal of Infectious Diseases and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.